» Articles » PMID: 19826812

Type I Interferons Inhibit the Generation of Tumor-associated Macrophages

Overview
Date 2009 Oct 15
PMID 19826812
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor-associated macrophages (TAM) are very abundant in tumors and are thought to play a major role in promoting tumor growth. The generation of TAM is positively regulated by several cytokines, including colony stimulating factor-1 (CSF-1) and monocyte chemoattractant protein-1 (CCL2). However, endogenous factors that suppress the generation of TAM within tumors have not been previously identified. An earlier study showed that endogenously produced type I interferons (IFN) suppressed tumor growth via their effects on hematopoietic cells rather than through direct effects on tumor cells. Therefore, we used mouse tumor models to investigate the effects of endogenously produced type I IFNs on the generation of TAM. We found using immunohistochemistry and flow cytometry that TAM density was significantly increased in tumors of mice lacking the type I IFN receptor (IFN-alpha/betaR(-/-) mice) compared to wild type mice. Moreover, the increase in TAM density was associated with a significant increase in tumor growth rate and angiogenesis. The phenotype of TAM was similar in IFN-alpha/betaR(-/-) mice and wild type mice and tumors in both mice produced similar amounts of CSF-1 and CCL2. However, in vitro assays indicated that low concentrations of type I IFNs significantly inhibited the generation of bone marrow macrophages in response to CSF-1. These findings indicate that endogenously produced type I IFNs suppress the generation of TAM, which may in turn account for inhibition of tumor growth and angiogenesis.

Citing Articles

The Role of the Microbiome and of Radiotherapy-Derived Metabolites in Breast Cancer.

Herrera-Quintana L, Vazquez-Lorente H, Silva R, Olivares-Arancibia J, Reyes-Amigo T, Pires B Cancers (Basel). 2024; 16(21).

PMID: 39518108 PMC: 11545256. DOI: 10.3390/cancers16213671.


Metabolic mediators: microbial-derived metabolites as key regulators of anti-tumor immunity, immunotherapy, and chemotherapy.

Lu S, Wang C, Ma J, Wang Y Front Immunol. 2024; 15:1456030.

PMID: 39351241 PMC: 11439727. DOI: 10.3389/fimmu.2024.1456030.


Inhibitory receptors of plasmacytoid dendritic cells as possible targets for checkpoint blockade in cancer.

Tiberio L, Laffranchi M, Zucchi G, Salvi V, Schioppa T, Sozzani S Front Immunol. 2024; 15:1360291.

PMID: 38504978 PMC: 10948453. DOI: 10.3389/fimmu.2024.1360291.


Hypoxic glioblastoma-cell-derived extracellular vesicles impair cGAS-STING activity in macrophages.

Tankov S, Petrovic M, Lecoultre M, Espinoza F, El-Harane N, Bes V Cell Commun Signal. 2024; 22(1):144.

PMID: 38389103 PMC: 10882937. DOI: 10.1186/s12964-024-01523-y.


Reprogramming of tumor-associated macrophages via NEDD4-mediated CSF1R degradation by targeting USP18.

Miyauchi S, Arimoto K, Liu M, Zhang Y, Zhang D Cell Rep. 2023; 42(12):113560.

PMID: 38100351 PMC: 10822669. DOI: 10.1016/j.celrep.2023.113560.


References
1.
von Marschall Z, Scholz A, Cramer T, Schafer G, Schirner M, Oberg K . Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis. J Natl Cancer Inst. 2003; 95(6):437-48. DOI: 10.1093/jnci/95.6.437. View

2.
Kubota Y, Ito K . Chemotactic migration of mesencephalic neural crest cells in the mouse. Dev Dyn. 2000; 217(2):170-9. DOI: 10.1002/(SICI)1097-0177(200002)217:2<170::AID-DVDY4>3.0.CO;2-9. View

3.
Tsutsui S, Yasuda K, Suzuki K, Tahara K, Higashi H, Era S . Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. Oncol Rep. 2005; 14(2):425-31. View

4.
Moore R, Larsen H, Horohov D, Rouse B . Endogenous regulation of macrophage proliferative expansion by colony-stimulating factor-induced interferon. Science. 1984; 223(4632):178-81. DOI: 10.1126/science.6606850. View

5.
Lewis C, Pollard J . Distinct role of macrophages in different tumor microenvironments. Cancer Res. 2006; 66(2):605-12. DOI: 10.1158/0008-5472.CAN-05-4005. View